262 related articles for article (PubMed ID: 30094467)
1. Toll-like receptor 9 negatively regulates pancreatic islet beta cell growth and function in a mouse model of type 1 diabetes.
Liu M; Peng J; Tai N; Pearson JA; Hu C; Guo J; Hou L; Zhao H; Wong FS; Wen L
Diabetologia; 2018 Nov; 61(11):2333-2343. PubMed ID: 30094467
[TBL] [Abstract][Full Text] [Related]
2. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
[TBL] [Abstract][Full Text] [Related]
3. TLR9 Deficiency in B Cells Promotes Immune Tolerance via Interleukin-10 in a Type 1 Diabetes Mouse Model.
Sha S; Pearson JA; Peng J; Hu Y; Huang J; Xing Y; Zhang L; Zhu Y; Zhao H; Wong FS; Chen L; Wen L
Diabetes; 2021 Feb; 70(2):504-515. PubMed ID: 33154070
[TBL] [Abstract][Full Text] [Related]
4. The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes.
Tai N; Wong FS; Wen L
J Autoimmun; 2016 Jul; 71():26-34. PubMed ID: 27021275
[TBL] [Abstract][Full Text] [Related]
5. Involvement of long non-coding RNAs in beta cell failure at the onset of type 1 diabetes in NOD mice.
Motterle A; Gattesco S; Caille D; Meda P; Regazzi R
Diabetologia; 2015 Aug; 58(8):1827-35. PubMed ID: 26037202
[TBL] [Abstract][Full Text] [Related]
6. IDO mediates TLR9-driven protection from experimental autoimmune diabetes.
Fallarino F; Volpi C; Zelante T; Vacca C; Calvitti M; Fioretti MC; Puccetti P; Romani L; Grohmann U
J Immunol; 2009 Nov; 183(10):6303-12. PubMed ID: 19841163
[TBL] [Abstract][Full Text] [Related]
7. Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development.
Green-Mitchell SM; Tersey SA; Cole BK; Ma K; Kuhn NS; Cunningham TD; Maybee NA; Chakrabarti SK; McDuffie M; Taylor-Fishwick DA; Mirmira RG; Nadler JL; Morris MA
PLoS One; 2013; 8(2):e56763. PubMed ID: 23437231
[TBL] [Abstract][Full Text] [Related]
8. Glucose and inflammation control islet vascular density and beta-cell function in NOD mice: control of islet vasculature and vascular endothelial growth factor by glucose.
Akirav EM; Baquero MT; Opare-Addo LW; Akirav M; Galvan E; Kushner JA; Rimm DL; Herold KC
Diabetes; 2011 Mar; 60(3):876-83. PubMed ID: 21307078
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic beta cell autophagy is impaired in type 1 diabetes.
Muralidharan C; Conteh AM; Marasco MR; Crowder JJ; Kuipers J; de Boer P; Linnemann AK
Diabetologia; 2021 Apr; 64(4):865-877. PubMed ID: 33515072
[TBL] [Abstract][Full Text] [Related]
10. Proposed mechanisms for oligonucleotide IMT504 induced diabetes reversion in a mouse model of immunodependent diabetes.
Bianchi MS; Bianchi S; Hernado-Insúa A; Martinez LM; Lago N; Libertun C; Chasseing NA; Montaner AD; Lux-Lantos VA
Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E380-95. PubMed ID: 27329801
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota from B-cell-specific TLR9-deficient NOD mice promote IL-10
Yang X; Huang J; Peng J; Wang P; Wong FS; Wang R; Wang D; Wen L
Front Immunol; 2024; 15():1413177. PubMed ID: 38903498
[TBL] [Abstract][Full Text] [Related]
12. The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice.
Wong FS; Hu C; Zhang L; Du W; Alexopoulou L; Flavell RA; Wen L
Ann N Y Acad Sci; 2008 Dec; 1150():146-8. PubMed ID: 19120284
[TBL] [Abstract][Full Text] [Related]
13. TLR4 signals through islet macrophages to alter cytokine secretion during diabetes.
Chittezhath M; Wai CMM; Tay VSY; Chua M; Langley SR; Ali Y
J Endocrinol; 2020 Oct; 247(1):87. PubMed ID: 32755994
[TBL] [Abstract][Full Text] [Related]
14. Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene.
Melanitou E
Gene; 2020 Aug; 753():144785. PubMed ID: 32445922
[TBL] [Abstract][Full Text] [Related]
15. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.
Medina A; Parween S; Ullsten S; Vishnu N; Siu YT; Quach M; Bennet H; Balhuizen A; Åkesson L; Wierup N; Carlsson PO; Ahlgren U; Lernmark Å; Fex M
Diabetologia; 2018 Apr; 61(4):896-905. PubMed ID: 29209740
[TBL] [Abstract][Full Text] [Related]
16. Deficiency in type I interferon signaling prevents the early interferon-induced gene signature in pancreatic islets but not type 1 diabetes in NOD mice.
Quah HS; Miranda-Hernandez S; Khoo A; Harding A; Fynch S; Elkerbout L; Brodnicki TC; Baxter AG; Kay TW; Thomas HE; Graham KL
Diabetes; 2014 Mar; 63(3):1032-40. PubMed ID: 24353186
[TBL] [Abstract][Full Text] [Related]
17. TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice.
Tai N; Wong FS; Wen L
J Immunol; 2013 Sep; 191(6):2926-37. PubMed ID: 23956420
[TBL] [Abstract][Full Text] [Related]
18. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome.
Kondo M; Tanabe K; Amo-Shiinoki K; Hatanaka M; Morii T; Takahashi H; Seino S; Yamada Y; Tanizawa Y
Diabetologia; 2018 Oct; 61(10):2189-2201. PubMed ID: 30054673
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors and type 1 diabetes.
Zipris D
Adv Exp Med Biol; 2010; 654():585-610. PubMed ID: 20217515
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes.
Pechhold K; Zhu X; Harrison VS; Lee J; Chakrabarty S; Koczwara K; Gavrilova O; Harlan DM
Diabetes; 2009 May; 58(5):1175-84. PubMed ID: 19228810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
